What is 10XBeta?
10XBeta operates as a specialized venture studio that integrates capital, technical resources, and manufacturing expertise to accelerate the development of medical devices. By providing a comprehensive ecosystem for founders, the company streamlines the complex journey from initial prototype to full-scale production. Their market position is defined by an ability to navigate stringent regulatory environments while simultaneously offering in-house manufacturing capabilities, which significantly reduces time-to-market for high-potential startups. By collaborating with leading healthcare organizations, 10XBeta effectively mitigates the risks typically associated with early-stage medical device commercialization, ensuring that patient-centric innovations reach clinical settings with greater efficiency.
How much funding has 10XBeta raised?
10XBeta has raised a total of $173K across 1 funding round:
Debt
$173K
Debt (2021): $173K with participation from PPP
Key Investors in 10XBeta
PPP
Public-Private Partnership
What's next for 10XBeta?
With the recent infusion of capital, 10XBeta is well-positioned to scale its internal manufacturing infrastructure and expand its portfolio of HealthTech ventures. The strategic focus will likely shift toward optimizing regulatory pathways and deepening partnerships with healthcare providers to facilitate broader adoption of their incubated technologies. As the firm moves into this next phase of growth, the emphasis will remain on leveraging its unique venture studio model to drive sustainable improvements in patient outcomes. By maintaining a rigorous focus on product development and commercialization, 10XBeta is poised to remain a dominant force in the medical device innovation landscape, attracting further interest from institutional investors seeking exposure to high-impact healthcare solutions.
See full 10XBeta company page
